Tateda Kazuhiro, Kusano Emiko, Matsumoto Tetsuya, Kimura Kazuhiro, Uchida Koh, Nakata Koichiro, Yamaguchi Keizo
Department of Microbiology and Infectious Disease, Toho University School of Medicine, Ohmori-nishi, Tokyo, Japan.
Scand J Infect Dis. 2006;38(3):166-71. doi: 10.1080/00365540500400944.
Detection of urinary antigen by a rapid immunochromatographic membrane test (Binax NOW) was widely accepted as a powerful tool for diagnosis of Streptococcus pneumoniae pneumonia. This is a qualitative kit, so the value of quantitative analysis of urinary antigen, especially correlation of antigen titers and severity of diseases, remained to be determined. We examined semi-quantitative antigen titer in urines collected from urinary antigen-proven S. pneumoniae pneumonia on admission, and analyzed the kinetics of antigen titer and its relation to severity of diseases. After serial 2-fold dilution of urine, the highest dilution for positive results was determined, and this was designated as maximum dilution factor (MDF). MDFs varied from 1 to 4096 in 29 patients examined (mean MDF, 317.8). Importantly, severe cases of S. pneumoniae pneumonia were higher values of MDFs (mean MDF: 760.5) than those of non-severe cases (mean MDF: 5.4). The patients with high MDFs (> or = 64) demonstrated higher values of LDH, CRP and lower values of WBC and PaO2 compared to those of low MDFs group (< or = 32). There was no clear correlation between CRP values and antigen titers, and conversely the majority of severe cases showed relatively weak CRP responses, despite high levels of bacterial antigen. Kinetic analysis of urinary and serum antigen titers in 4 cases of S. pneumoniae pneumonia exhibited consistently higher values of antigen titers in urine than those in serum. The half lives of urinary and serum antigen titers were calculated to be 1.0-3.4 and 1.1-2.3 weeks, respectively. These data suggest that quantitative analysis of urinary antigen may be a useful indicator for severity of disease and course of S. pneumoniae pneumonia. Our results demonstrate an application for S. pneumoniae antigen titer determination in urine and serum, which may be crucial not only for diagnostic measures, but also may provide a better understanding of the pathogenesis of S. pneumoniae infection.
通过快速免疫层析膜试验(Binax NOW)检测尿抗原被广泛认为是诊断肺炎链球菌肺炎的有力工具。这是一种定性试剂盒,因此尿抗原定量分析的价值,尤其是抗原滴度与疾病严重程度的相关性,仍有待确定。我们检测了入院时经尿抗原证实的肺炎链球菌肺炎患者尿液中的半定量抗原滴度,并分析了抗原滴度的动力学及其与疾病严重程度的关系。尿液经连续2倍稀释后,确定阳性结果的最高稀释度,将其指定为最大稀释倍数(MDF)。在检测的29例患者中,MDF范围为1至4096(平均MDF为317.8)。重要的是,肺炎链球菌肺炎重症病例的MDF值(平均MDF:760.5)高于非重症病例(平均MDF:5.4)。与低MDF组(≤32)相比,高MDF组(≥64)患者的乳酸脱氢酶(LDH)、C反应蛋白(CRP)值较高,白细胞(WBC)和动脉血氧分压(PaO2)值较低。CRP值与抗原滴度之间无明显相关性,相反,尽管细菌抗原水平较高,但大多数重症病例的CRP反应相对较弱。对4例肺炎链球菌肺炎患者的尿和血清抗原滴度进行动力学分析,结果显示尿液中的抗原滴度始终高于血清中的抗原滴度。计算得出尿和血清抗原滴度的半衰期分别为1.0 - 3.4周和1.1 - 2.3周。这些数据表明,尿抗原定量分析可能是肺炎链球菌肺炎疾病严重程度和病程的有用指标。我们的结果证明了尿和血清中肺炎链球菌抗原滴度测定的应用,这不仅对诊断措施可能至关重要,而且可能有助于更好地理解肺炎链球菌感染的发病机制。